NO914071D0 - Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser

Info

Publication number
NO914071D0
NO914071D0 NO914071A NO914071A NO914071D0 NO 914071 D0 NO914071 D0 NO 914071D0 NO 914071 A NO914071 A NO 914071A NO 914071 A NO914071 A NO 914071A NO 914071 D0 NO914071 D0 NO 914071D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutic active
relations
active relations
Prior art date
Application number
NO914071A
Other languages
English (en)
Other versions
NO914071L (no
Inventor
Jonathan Frost
Patrick Lardenois
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO914071D0 publication Critical patent/NO914071D0/no
Publication of NO914071L publication Critical patent/NO914071L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO91914071A 1990-10-18 1991-10-17 Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser NO914071L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9012872A FR2668149B1 (fr) 1990-10-18 1990-10-18 Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique.

Publications (2)

Publication Number Publication Date
NO914071D0 true NO914071D0 (no) 1991-10-17
NO914071L NO914071L (no) 1992-04-21

Family

ID=9401336

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914071A NO914071L (no) 1990-10-18 1991-10-17 Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser

Country Status (18)

Country Link
US (1) US5212181A (no)
EP (1) EP0481853A1 (no)
JP (1) JPH04257579A (no)
KR (1) KR920008029A (no)
AU (1) AU638173B2 (no)
CA (1) CA2052760A1 (no)
CS (1) CS315291A3 (no)
FI (1) FI914906A (no)
FR (1) FR2668149B1 (no)
HU (1) HUT59391A (no)
IE (1) IE913653A1 (no)
IL (1) IL99779A0 (no)
MX (1) MX9101604A (no)
NO (1) NO914071L (no)
NZ (1) NZ240261A (no)
PL (1) PL292089A1 (no)
PT (1) PT99247A (no)
ZA (1) ZA918293B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524846A1 (fr) * 1991-06-27 1993-01-27 Synthelabo Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique
US6255322B1 (en) * 1992-06-19 2001-07-03 Pfizer Inc. 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
FR2699534B1 (fr) * 1992-12-21 1995-02-03 Synthelabo Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique.
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
WO1998049900A1 (en) * 1997-05-07 1998-11-12 Emory University Haloisoquinoline carboxamide
AU2003248122A1 (en) * 2002-07-25 2004-02-16 Kotobuki Pharmaceutical Co., Ltd. Sodium channel inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
NZ240261A (en) 1993-01-27
AU8589291A (en) 1992-04-30
JPH04257579A (ja) 1992-09-11
HU913267D0 (en) 1992-01-28
IE913653A1 (en) 1992-04-22
CS315291A3 (en) 1992-05-13
PL292089A1 (en) 1992-06-26
HUT59391A (en) 1992-05-28
FI914906A0 (fi) 1991-10-17
IL99779A0 (en) 1992-08-18
FR2668149A1 (fr) 1992-04-24
EP0481853A1 (fr) 1992-04-22
NO914071L (no) 1992-04-21
US5212181A (en) 1993-05-18
MX9101604A (es) 1992-06-05
PT99247A (pt) 1992-08-31
FI914906A (fi) 1992-04-19
CA2052760A1 (en) 1992-04-19
KR920008029A (ko) 1992-05-27
ZA918293B (en) 1992-07-29
AU638173B2 (en) 1993-06-17
FR2668149B1 (fr) 1994-09-23

Similar Documents

Publication Publication Date Title
NO914667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
NO914036D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater
NO912672L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oligomerer.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO903088L (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO910874L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO890155L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO173185C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
NO900697D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
NO304428B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler
NO904800L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamater.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO169486C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive allylaminoetylazoler
NO880841D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO171849C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkenyl-dioksaner